James M. Isbell

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

Pedram Razavi, Bob T. Li, David N. Brown et al. · Nature Medicine · 2019 · 718 citations · Full text

Dna Sequencing, Sequencing, High-intensity Sequencing +12

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde et al. · Annals of Oncology · 2018 · 557 citations · Full text

Damage Control Hematology: The Impact of a Trauma Exsanguination Protocol on Survival and Blood Product Utilization

Bryan A. Cotton, Oliver L. Gunter, James M. Isbell et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2008 · 413 citations

Trauma Resuscitation, Traumatology, Vascular Trauma +19

Optimizing Outcomes in Damage Control Resuscitation: Identifying Blood Product Ratios Associated With Improved Survival

Oliver L. Gunter, Brigham K. Au, James M. Isbell et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2008 · 357 citations

Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

Valsamo Anagnostou, Patrick M. Forde, James R. White et al. · Cancer Research · 2018 · 308 citations · Full text